Companies
Merck
PharmaceuticalsRahway, New JerseyMRKAbout 75,000 employees
WorkHush has 4 source-backed updates on Merck workforce changes since July 2025. The latest, added September 8, 2026: 54 Rahway, New Jersey jobs in September 2026 WARN notice (WARN notice). The next layoff date on record is December 11, 2026. Read it with sources ›
More about Merck
Drugmaker that develops and sells prescription medicines, vaccines and animal health products
Revenue
$65.0B
Fiscal 2025, up 1.3%
Employees
About 75,000
As of December 2025
Stock
MRK
New York Stock Exchange
Headquarters
Rahway, New Jersey
CEO
Robert Davis
Since July 2021
BrandsKeytruda, Gardasil, Winrevair, Januvia, MSD Animal Health
Current strategyCutting $3B in annual costs by the end of 2027 and reinvesting in new products ahead of Keytruda's loss of exclusivity
Recent workforce changesAbout 6,000 jobs cut under a restructuring announced in July 2025; 88 more at Rahway in September 2026
CompetitorsPfizer, Bristol Myers Squibb, AstraZeneca
Related companiesBristol Myers SquibbPfizerZoetis
Checked October 11, 2026 · Sources: sec.gov, pharmexec.com, guidechem.com
Merck · WARN notice54 Rahway, New Jersey jobs in September 2026 WARN noticeNew Jersey WARN notice posted September 2026; effective December 11, 2026 and January 4, 2027 · Sources: New Jersey Department of Labor WARN report, NJBIZ, Fierce PharmaMerck · WARN notice88 Rahway, New Jersey jobs in June 2026 WARN noticeNew Jersey WARN notice posted June 2026; effective September 4, 2026 · Sources: New Jersey Department of Labor WARN report, NJBIZMerck · WARN notice204 Rahway, New Jersey jobs in November 2025 WARN noticeNew Jersey WARN notice posted November 2025; effective February 20, March 6, March 13 and May 11, 2026 · Sources: New Jersey Department of Labor WARN report (2025), NJBIZMerck · Announced planAbout 6,000 roles to be cut under multiyear cost-savings programAnnounced July 29, 2025 · Sources: SEC Form 8-K, Pharmaceutical Executive, Fierce Pharma
No one has posted about Merck yet. Be the first to post ›
Follow Merck in a feed reader, no account needed: RSS feed